BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 1 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $183,557 | +3.2% | 2,074,551 | +1.1% | 0.32% | +9.8% |
| Q2 2023 | $177,808 | -11.2% | 2,051,316 | -0.4% | 0.29% | -17.3% |
| Q1 2023 | $200,251 | -7.4% | 2,059,347 | -1.5% | 0.35% | -19.9% |
| Q4 2022 | $216,269 | -99.9% | 2,089,754 | -4.6% | 0.43% | +15.2% |
| Q3 2022 | $185,686,000 | -1.5% | 2,190,467 | -3.7% | 0.38% | +7.4% |
| Q2 2022 | $188,489,000 | +7.3% | 2,274,521 | -0.1% | 0.35% | +48.9% |
| Q1 2022 | $175,618,000 | -13.7% | 2,277,794 | -1.2% | 0.24% | -4.5% |
| Q4 2021 | $203,602,000 | +8.5% | 2,304,490 | -5.1% | 0.25% | +6.5% |
| Q3 2021 | $187,590,000 | -5.0% | 2,427,099 | +2.6% | 0.23% | -3.3% |
| Q2 2021 | $197,478,000 | – | 2,366,716 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 52,096 | $55,672 | 3.77% |
| MACKAY SHIELDS LLC | 77,043,000 | $83,172,605 | 2.12% |
| Sonora Investment Management Group, LLC | 7,960,000 | $8,654,409 | 0.79% |
| Lombard Odier Asset Management (Europe) Ltd | 12,390,000 | $17,994,379 | 0.73% |
| BRAIDWELL LP | 19,200,000 | $20,727,568 | 0.70% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 32,064,000 | $34,615,044 | 0.60% |
| LOOMIS SAYLES & CO L P | 2,089,754 | $216,269 | 0.43% |
| Liberty Mutual Group Asset Management Inc. | 825,000 | $887 | 0.24% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,143,000 | $3,386,583 | 0.09% |
| THRIVENT FINANCIAL FOR LUTHERANS | 15,950,000 | $17,139 | 0.04% |